“Synthesis and biological evaluation of (4-Fluorophenyl)(1-(5-phenyl-1,3,4-oxadiazol-2-yl)indolizin-3-yl)methanone derivatives as anticancer and antimicrobial agents” (2022) International Journal of Pharmaceutical Sciences and Drug Research, 14(1), pp. 8–18. doi:10.25004/IJPSDR.2022.140102.